2007
DOI: 10.1016/j.jchromb.2007.04.047
|View full text |Cite
|
Sign up to set email alerts
|

Determination of palmatine in canine plasma by liquid chromatography–tandem mass spectrometry with solid-phase extraction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
11
0

Year Published

2008
2008
2017
2017

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(12 citation statements)
references
References 8 publications
1
11
0
Order By: Relevance
“…6). These results are consistent with those of palmatine (C 21 H 22 NO 4 , MW 352; Huang et al, 2007;Lu and Yang, 2004;Zhang et al, 2006). The mechanistic pathway for fragments formed may be explained according to Scheme 3.…”
Section: Identification Of Compounds 3 Andsupporting
confidence: 86%
See 1 more Smart Citation
“…6). These results are consistent with those of palmatine (C 21 H 22 NO 4 , MW 352; Huang et al, 2007;Lu and Yang, 2004;Zhang et al, 2006). The mechanistic pathway for fragments formed may be explained according to Scheme 3.…”
Section: Identification Of Compounds 3 Andsupporting
confidence: 86%
“…It is impossible to obtain their effective constituents by traditional methods like pure compounds isolation, structure elucidation and then individual pharmacological tests. Therefore, methods to reveal the effective substances are in great demand (Ye et al, 2007). In fact, for most oral administrative TCMFs, only part of constituents successfully absorbed into blood and kept at a considerable concentration level in target organs can be responsible for the curative effects.…”
Section: Introductionmentioning
confidence: 99%
“…Although the pharmacological effects of BER and other Coptis extracts have been widely reported, information regarding their oral absorption remains to be fully elucidated. Previous pharmacokinetic studies have demonstrated that the four protoberberine alkaloids have markedly low plasma concentrations and poor oral bioavailability in rats, beagle dogs and humans following oral administration (24)(25)(26)(27). Furthermore, several studies have reported that BER is a P-glycoprotein (P-gp)…”
Section: Introductionmentioning
confidence: 99%
“…The results also showed that although the chemical structures of the six alkaloids were similar, their pharmacokinetic behaviors were different. As in the literatures [18,19], the pharmacokinetic parameters after administration of BB and PM were studied, and we could found that there were more peaks in the decoction and the T max were longer than individual compounds, which meant there might be synergistic effects after administration of the decoction.…”
Section: Resultsmentioning
confidence: 90%